Literature DB >> 8259396

Captopril renography and the hypertensive renal transplantation patient: a predictive test of therapeutic outcome.

K K Shamlou1, W E Drane, I F Hawkins, R S Fennell.   

Abstract

PURPOSE: To detect predictive accuracy of captopril renography in transplant recipients with hypertension.
MATERIALS AND METHODS: This prospective study was performed to evaluate findings on 18 renal scans acquired after administration of captopril (captopril renograms) in 14 transplantation patients with new-onset or poorly controlled hypertension. Captopril renography was not used to affect case management but to predict response to angioplasty.
RESULTS: Arteriograms were abnormal in 12 of 18 studies. In the six cases in which angiograms were normal, captopril renograms also were normal. In the 12 cases in which angiograms were abnormal, captopril renograms were normal in five and abnormal in seven. In the five cases in which renograms were normal, hypertension did not improve, although angioplasty was technically successful. In the seven with abnormal renograms, four patients underwent angioplasty with excellent results. These patients had a significant (P < .05) decrease in diastolic blood pressure (-15 mm Hg) and in creatinine concentration (-0.4 mg/dL) compared with patients with normal renograms and abnormal angiograms.
CONCLUSION: In this small population, captopril renography appeared to be predictive of physiologically meaningful renal artery stenosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8259396     DOI: 10.1148/radiology.190.1.8259396

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  2 in total

1.  Differences between 99mTc-DTPA and 99mTc-MAG3 captopril renographies in renovascular hypertension.

Authors:  K Itoh; Y Matsui; C Kato; T Mochizuki; A Kitabatake
Journal:  Ann Nucl Med       Date:  1996-05       Impact factor: 2.668

2.  Captopril scintigraphy in the study of arterial hypertension in pediatrics.

Authors:  Edda Lagomarsino; Pilar Orellana; Jaime Muñoz; Claudia Velásquez; Felipe Cavagnaro; Francisco Valdés
Journal:  Pediatr Nephrol       Date:  2003-11-25       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.